These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6649586)

  • 1. [High-density lipoprotein cholesterol and the atherogenic index in patients with different types of hyperlipoproteinemias].
    Apostolov I; Naumova R; Balabanski L; Goranov I
    Vutr Boles; 1983; 22(3):70-4. PubMed ID: 6649586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High density lipoprotein cholesterol in secondary hyperlipoproteinemias].
    Titov VN; Tvorogova MG; Kantardzhian IG; Alamdarova IA; Negovskaia AV
    Lab Delo; 1983; (12):11-7. PubMed ID: 6201650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in serum lipoproteins in patients with ischemic heart disease at an early age].
    Malamov E; Kiriakov A; Tsenov I; Kavrukova Iu; Kusitasev G
    Vutr Boles; 1982; 21(2):91-8. PubMed ID: 7101895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical research on the hypolipidemic action of a probucol preparation].
    Naumova R; Kerekovska M; Goranov I; Balabanski L
    Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apolipoprotein E and activity of cholesterol esters transport in type IIA and IIB hyperlipoproteinemia].
    Tvorogova MG; Rozhkova TA; Semenova OA; Lupanov VP; Nuraliev EIu ; Kukharchuk VV; Titov VN
    Ter Arkh; 1997; 69(12):30-3. PubMed ID: 9503530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of 1 month's treatment with Bezalip on the serum lipids and lipoproteins of patients with different types of hyperlipoproteinemias].
    Kiriakov A; Malamov E; Apostolova Iu; Tsenov I; Tinterova Z
    Vutr Boles; 1983; 22(3):74-81. PubMed ID: 6649587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Features of lipid metabolism in patients of different sexes and ages with dyscirculatory encephalopathy].
    Shprakh VV; Burtsev EM; Ruzhnikova TV; Naumova TV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1308-13. PubMed ID: 4072526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G; Fragiacomo C; Weidmann P; Bachmann C
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid abnormalities in coronary heart disease: a population-based case-control study.
    Gupta R; Kaul V; Prakash H; Sarna M; Singhal S; Gupta VP
    Indian Heart J; 2001; 53(3):332-6. PubMed ID: 11516034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of low density and high density lipoprotein cholesterol by fat-modified diets. A survey of recent findings.
    Vessby B; Lithell H; Boberg J
    Hum Nutr Clin Nutr; 1982; 36(3):203-11. PubMed ID: 6749766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects.
    Ferlito S; Ricceri M; Ossino AM
    Int Angiol; 1989; 8(3):140-4. PubMed ID: 2592796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperlipoproteinemia in necrotizing pancreatitis].
    Modzelewski B; Janiak A; Hołlyński J
    Pol Merkur Lekarski; 2005 Apr; 18(106):415-7. PubMed ID: 16161923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peculiarities of lipid and protein components of the high- and low-density lipoproteins in patients suffering from coronary atherosclerosis with different number of affected coronary arteries.
    Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaya TI; Polessky VA; Matveeva LS
    Cor Vasa; 1981; 23(4):248-56. PubMed ID: 7297073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J; Bar-On H; Shafrir E
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High density lipoprotein and arteriosclerosis. Different patterns in primary hypothyroidism and type IIa hyperlipoproteinemia.
    Brook JG; Aviram M; Luboshitzky R; Barzilai D
    Isr J Med Sci; 1981 May; 17(5):318-22. PubMed ID: 7263188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate].
    Schiffl H; Weidmann P; Fragiacomo C; Noseda G; Bachmann C
    Schweiz Med Wochenschr; 1985 Jun; 115(26):907-11. PubMed ID: 3927481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phospholipid characteristics of the HDLP2 and HDLP3 composition in dysalphalipoproteinemia].
    Gerasimova EN; Pham TM; Suchkova SN; Chepurnenko NV; Polesskiĭ VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(2):86-93. PubMed ID: 7053079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.